Active substance
Results for the substance alpha agalsidase
1 result
About this active substance
Agalsidase alfa is a medication used for the treatment of Fabry disease, a rare genetic disorder caused by the accumulation of globotriaosylceramide in cells. It is an enzyme replacement therapy that helps break down and remove this substance from the body.
It is administered via intravenous infusion, usually once every two weeks, under the supervision of a specialist. Treatment with agalsidase alfa can reduce symptoms of Fabry disease, such as pain, fatigue, and organ damage.
Side effects may include infusion site reactions, fever, headaches, or nausea. In rare cases, severe allergic reactions may occur.
Patients should be regularly monitored to assess the effectiveness of the treatment and to identify any adverse reactions. It is important to follow the doctor's recommendations to achieve the best outcomes.
It is administered via intravenous infusion, usually once every two weeks, under the supervision of a specialist. Treatment with agalsidase alfa can reduce symptoms of Fabry disease, such as pain, fatigue, and organ damage.
Side effects may include infusion site reactions, fever, headaches, or nausea. In rare cases, severe allergic reactions may occur.
Patients should be regularly monitored to assess the effectiveness of the treatment and to identify any adverse reactions. It is important to follow the doctor's recommendations to achieve the best outcomes.